Ophthalmic Laser Study day

Ophthalmic Laser Study Day 2012

Carleton Optical in association with IRIDEX are pleased to announce plans for an ophthalmic laser awareness study day.

Subjects to be covered will include innovative treatments for diabetic retinopathy, an update on transcleral cyclophotocoagulation and a review of the IQ 577nm Yellow Laser. Whilst timings are yet to be confirmed, it will be a London venue probably in the second half of July 2012.

In order to help us with planning kindly register your interest at carleton@carletonltd.com and we will acknowledge your interest and submit a registration form.

IRIDEX Corporation, founded in 1989 is a world leader in developing, manufacturing, marketing leading edge and versatile laser-based medical systems and delivery devices. The innovative tissue sparing modality MicroPulse™ is an example of progressive laser treatment therapy developed by IRIDEX and available on the majority of their laser platforms.

For further information about this or any of Carletons expentive ophthalmic product range please contact us at Carleton-Tel- 01494 775811 email- carleton@carletonltd.com

Event schedule
27 January, 2012 - 30 June, 2012
 
 

Latest News

Subscribe via RSS Syndicate content

dio-banner.jpg

Events

  • 27 January, 2012 - 30 June, 2012

    Ophthalmic Laser Study Day 2012

    Carleton Optical in association with IRIDEX are pleased to announce plans for an ophthalmic laser awareness study day.

    Subjects to be covered will include innovative treatments for diabetic retinopathy, an update on transcleral cyclophotocoagulation and a review of the IQ 577nm Yellow Laser. Whilst timings are yet to be confirmed, it will be a London venue probably in the second half of July 2012.